Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages

  Hutfless, Susan M ^a   Matos, Peter ^b,c   Talor, Monica V ^a,d   Caturegli, Patrizio ^a   Rose, Noel R ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c Headquarters Joint Munitions Command   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AFRICAN AMERICAN; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLDIER;

AUTOANTIBODIES; AUTOANTIGENS; CASE-CONTROL STUDIES; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; RECEPTORS, THYROTROPIN; THYROGLOBULIN;

EID: 80052517559     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0228     Document Type: Article

References (19)

1. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., Braverman L.E. 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499 (Pubitemid 34158210)
2. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M. 1997 Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223-243 (Pubitemid 27398022)
3. Yeatts R.P. 2005 Quality of life in patients with Graves ophthalmopathy. Trans Am Ophthalmol Soc 103:368-411
4. Burman K.D. 1997 Thyroid disease and osteoporosis. Hosp Pract (Minneap) 32:71-73, 78-85; discussion 85-86
5. Rodondi N., Den Elzen W.P., Bauer D.C., Cappola A.R., Razvi S., Walsh J.P., Asvold B.O., Iervasi G., Imaizumi M., Collet T.H., Bremner A., Maisonneuve P., Sgarbi J.A., Khaw K.T., Vanderpump M.P., Newman A.B., Cornuz J., Franklyn J.A., Westendorp R.G., Vittinghoff E., Gussekloo J. 2010 Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365-1374
6. Rose N.R. 2007 Prediction and prevention of autoimmune disease: A personal perspective. Ann NY Acad Sci 1109:117-128 (Pubitemid 47511351)
7. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., Eisenbarth G.S. 1996 Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933 (Pubitemid 26225509)
8. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., Harley J.B. 2003 Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526-1533 (Pubitemid 37255038)
9. Raptopoulou A., Sidiropoulos P., Katsouraki M., Boumpas D.T. 2007 Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: Evolving concepts. Crit Rev Clin Lab Sci 44:339-363 (Pubitemid 46897707)
10. Vanderpump M.P., Tunbridge W.M., French J.M., Appleton D., Bates D., Clark F., Grimley Evans J., Hasan D.M., Rodgers H., Tunbridge F., Young E.T. 1995 The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55-68
11. Effraimidis G., Strieder T.G., Tijssen J.G., Wiersinga W.M. 2011 Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: A prospective study. Eur J Endocrinol 164:107-113
12. Moore M., Eiseman E., Fisher G., Olmsted S.S., Sama P.R., Zambrano J.A. 2010 Harnessing Full Value from the DoD Serum Repository and the Defense Medical Surveillance System: RAND Corporation monograph series
13. Jahnke S.A., Haddock C.K., Poston W.S., Hoffman K.M., Hughey J., Lando H.A. 2010 A qualitative analysis of the tobacco control climate in the U.S. military. Nicotine Tob Res 12:88 -95
14. Arnson Y., Shoenfeld Y., Amital H. 2010 Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34:J258-J265
15. Vestergaard P. 2002 Smoking and thyroid disorders-a meta-analysis. Eur J Endocrinol 146:153-161
16. Belin R.M., Astor B.C., Powe N.R., Ladenson P.W. 2004 Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 89:6077-6086 (Pubitemid 39628417)
17. Strieder T.G., Prummel M.F., Tijssen J.G., Endert E., Wiersinga W.M. 2003 Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) 59:396-401 (Pubitemid 37046995)
18. Pedersen I.B., Laurberg P., Knudsen N., Jorgensen T., Perrild H., Ovesen L., Rasmussen L.B. 2008 Smoking is negatively associated with the presence of thyroglobulin autoantibody and to a lesser degree with thyroid peroxidase autoantibody in serum: A population study. Eur J Endocrinol 158:367-373 (Pubitemid 351405002)
19. Effraimidis G., Tijssen J.G., Wiersinga W.M. 2009 Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: A prospective study. J Clin Endocrinol Metab 94:1324-1328